Trials / Conditions / Von Willebrand Diseases

Von Willebrand Diseases

26 registered clinical trials studyying Von Willebrand Diseases — 10 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study NCT05916469	Oregon Health and Science University	—
Enrolling By Invitation	ATHNdataset Registry NCT06820515	American Thrombosis and Hemostasis Network	—
Recruiting	A Pilot Crossover Trial of Prophylactic Wilate Compared to Placebo for Heavy Menstrual Bleeding in Patients wi NCT06205095	Unity Health Toronto	Phase 3
Unknown	Impact of Von Willebrand Factor and Its Multimers on Angiogenesis NCT04810702	Nantes University Hospital	—
Completed	The Lived Experience of People With Von Willebrand Disease NCT06064643	Haemnet	—
Completed	Real-life Data of Constitutional Von Willebrand Disease in Western France NCT04887324	Nantes University Hospital	—
Recruiting	Videomicroscopy for the Prediction of Bleeding in Constitutional Haemorrhagic Diseases NCT04119908	University Hospital, Lille	N/A
Recruiting	Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID) NCT05776069	Vega Therapeutics, Inc	Phase 1 / Phase 2
Recruiting	Cardiovascular and Venous Thromboembolism Disease in Patients with Von Willebrand Disease in the French West NCT05773638	University Hospital, Brest	—
Completed	Prevent Postpartum Hemorrhage in Women With Von Willebrand Disease: The VWD-WOMAN Trial NCT04344860	Nicoletta C Machin	Phase 3
Completed	BT200 in Hereditary Bleeding Disorders NCT04677803	Medical University of Vienna	Phase 2
Recruiting	ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders NCT04398628	American Thrombosis and Hemostasis Network	—
Completed	Clinical Study to Investigate the Efficacy and Safety of Wilate During Prophylaxis in Previously Treated Patie NCT04052698	Octapharma	Phase 3
Unknown	A Study of Factor Inhibitors in Adult Patients With Hemophilia and Von Willebrand's Disease in Upper Egypt NCT04106323	Safaa AA Khaled	—
Completed	REAL-LIFE DATA OF CONSTITUTIONAL VON WILLEBRAND DISEASE IN WESTERN FRANCE (HOPSCOTcH-WILL) NCT03875924	Nantes University Hospital	—
Recruiting	Von Willebrand Factor in Pregnancy (VIP) Study NCT04146376	University of Washington	—
Unknown	Von Willebrand Antigen and Activity as Novel Biomarkers of Hemostasis in Inflammatory Bowel Disease NCT03715673	Assiut University	—
Completed	Bleeding Incidence in VWD Patients Undergoing On-Demand Treatment NCT04053699	Octapharma	—
Active Not Recruiting	ATHN 9: Severe VWD Natural History Study NCT03853486	American Thrombosis and Hemostasis Network	—
Recruiting	Development of a Device for Evaluating Primary Hemostasis Under Whole Blood Flow Conditions NCT03773159	Centre Hospitalier Universitaire Dijon	—
Terminated	Minimize Menorrhagia in Women With Von Willebrand Disease NCT02606045	Margaret Ragni	Phase 3
Completed	Clinical Performance Evaluation of T-TAS 01 PL Chip NCT03621020	Hikari Dx, Inc.	—
Recruiting	World Bleeding Disorders Registry NCT03327779	World Federation of Hemophilia	—
Completed	Frequency of Hemorrhages Associated With the Functional Anomalies of Willebrand Factor in Emergency Patients NCT03070912	University Hospital, Lille	—
Completed	Gingival Bleeding and Von Willebrand Disease Typ 2 and 3 NCT03078595	Goethe University	—
Completed	Prognostic Value of Implementing VCE on Top in Constitutional VWD-patients With GI-bleeding NCT04466878	University Hospital, Lille	—